Abstract
BackgroundMarket forces may not be sufficient to stimulate research and development of medicines for small patient populations, such as children and patients with rare diseases. Both the European Union Orphan...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have